Search Within

Hebert Alberto Vargas Alvarez

  1. "Genitourinary Oncology Service"
  2. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (1)
  3. Review (1)
Groups
  1. Department of Medicine (12)
  2. Genitourinary Oncology Service (12)
  3. Molecular Imaging and Therapy Service (12)
  4. Molecular Pharmacology and Chemistry Program Faculty (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Solid Tumor Oncology Division (12)

More Groups

People
  1. Howard Scher (10)
  2. Michael Morris (9)
  3. Hedvig Hricak (8)
  4. Steven Larson (6)
  5. Andreas Wibmer (5)
  6. Mithat Gonen (5)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2019 (2)
  4. 2018 (2)
  5. 2017 (2)
  6. 2015 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (2)
  2. Radiology (2)
  3. Clinical Genitourinary Cancer (1)
  4. European Urology Oncology (1)
  5. JAMA Oncology (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (2)
  2. Radiological Society of North America, Inc. (2)
  3. Society of Nuclear Medicine (2)
  4. American Medical Association (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation between imaging-based intermediate endpoints and overall survival in men with metastatic castration-resistant prostate cancer: Analysis of 28 randomized trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients
    Journal Article

    Woo, S.; Suh, C. H.; Wibmer, A. G.; Becker, A. S.; Teo, M. Y.; Gönen, M.; Hricak, H.; Scher, H. I.; Morris, M. J.; Vargas, H. A.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study
    Journal Article

    Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Comparison of magnetic resonance imaging-stratified clinical pathways and systematic transrectal ultrasound-guided biopsy pathway for the detection of clinically significant prostate cancer: A systematic review and meta-analysis of randomized controlled trials
    Review

    Woo, S.; Suh, C. H.; Eastham, J. A.; Zelefsky, M. J.; Morris, M. J.; Abida, W.; Scher, H. I.; Sidlow, R.; Becker, A. S.; Wibmer, A. G.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury
    Journal Article

    Bodo, S.; Campagne, C.; Thin, T. H.; Higginson, D. S.; Vargas, H. A.; Hua, G.; Fuller, J. D.; Ackerstaff, E.; Russell, J.; Zhang, Z.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Reproducibility and repeatability of semiquantitative (18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study
    Journal Article

    Vargas, H. A.; Kramer, G. M.; Scott, A. M.; Weickhardt, A.; Meier, A. A.; Parada, N.; Beattie, B. J.; Humm, J. L.; Staton, K. D.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer
    Journal Article

    O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Touijer, K. A.; Morris, M. J.; Danila, D. C.; Laudone, V. P.; Bochner, B. H.; Sheinfeld, J.; Dayan, E. S.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy
    Journal Article

    Robertson, N. L.; Sala, E.; Benz, M.; Landa, J.; Scardino, P.; Scher, H. I.; Hricak, H.; Vargas, H. A.
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • Association of overall survival with glycolytic activity of castrate-resistant prostate cancer metastases - Response
    Journal Article

    Vargas, H. A.; Wassberg, C.; Fox, J. J.; Wibmer, A.; Goldman, D. A.; Kuk, D.; Gonen, M.; Larson, S. M.; Morris, M. J.; Scher, H. I.; more...
    Radiology (2015)

    Fulltext@MSK | Save
  • Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging
    Journal Article

    Matulewicz, L.; Jansen, J. F. A.; Bokacheva, L.; Vargas, H. A.; Akin, O.; Fine, S. W.; Shukla-Dave, A.; Eastham, J. A.; Hricak, H.; Koutcher, J. A.; more...
    Journal of Magnetic Resonance Imaging (2014)

    Fulltext@MSK | Save